Genitourinary Cancer
Article
Can an app guide cancer treatment decisions during the pandemic?
Article
‘A good and peaceful death’: Cancer hospice during the pandemic
Conference Coverage
Germline testing in advanced cancer can lead to targeted treatment
In a study of nearly 12,000 cancer patients, 7%-9% of patients had targetable germline alterations.
News
FDA approves olaparib for certain metastatic prostate cancers
News
First PARP inhibitor approved for metastatic prostate cancer
News
Androgens may explain male vulnerability to COVID-19
News
COVID-19 death rate was twice as high in cancer patients in NYC study
The overall case fatality rate was 28% for cancer patients with COVID-19 and 14% for noncancer COVID-19 patients.
News
Three months of COVID-19 may mean 80,000 missed cancer diagnoses
A backlog of 22 million canceled or postponed tests for five common cancers is expected by early June.
News
Cancer screening, monitoring down during pandemic
Use of some tests came to “a near standstill” in early April.
News
Excess cancer deaths predicted as care is disrupted by COVID-19